Seidman Lawrence B Lifted Prudential Bancorp New (PBIP) Stake By $595,391, Celgene (CELG) Shorts Raised By 4.32%

June 19, 2017 - By Marguerite Chambers

Celgene Corporation (NASDAQ:CELG) had an increase of 4.32% in short interest. CELG’s SI was 9.36M shares in June as released by FINRA. Its up 4.32% from 8.98M shares previously. With 3.41M avg volume, 3 days are for Celgene Corporation (NASDAQ:CELG)’s short sellers to cover CELG’s short positions. The SI to Celgene Corporation’s float is 1.21%. About 2.10M shares traded. Celgene Corporation (NASDAQ:CELG) has risen 17.00% since June 19, 2016 and is uptrending. It has outperformed by 0.30% the S&P500.

Seidman Lawrence B increased Prudential Bancorp Inc New (PBIP) stake by 4.9% reported in 2016Q4 SEC filing. Seidman Lawrence B acquired 35,023 shares as Prudential Bancorp Inc New (PBIP)’s stock rose 5.26%. The Seidman Lawrence B holds 750,318 shares with $12.96M value, up from 715,295 last quarter. Prudential Bancorp Inc New now has $164.49M valuation. The stock declined 0.44% or $0.08 reaching $18.27 on the news. About 4,193 shares traded. Prudential Bancorp, Inc. of PA (NASDAQ:PBIP) has risen 25.00% since June 19, 2016 and is uptrending. It has outperformed by 8.30% the S&P500.

Investors sentiment decreased to 1.11 in Q4 2016. Its down 0.49, from 1.6 in 2016Q3. It dropped, as 4 investors sold PBIP shares while 5 reduced holdings. 3 funds opened positions while 7 raised stakes. 2.56 million shares or 2.97% less from 2.63 million shares in 2016Q3 were reported. Tower Rech Cap Limited (Trc) owns 759 shares. The California-based California Public Employees Retirement has invested 0% in Prudential Bancorp, Inc. of PA (NASDAQ:PBIP). Price T Rowe Md accumulated 20,035 shares. 358,490 were accumulated by Renaissance Technologies Ltd Liability Corp. Blackrock Fund has invested 0% in Prudential Bancorp, Inc. of PA (NASDAQ:PBIP). Creative Planning owns 10,000 shares. Vanguard Grp Inc has invested 0% in Prudential Bancorp, Inc. of PA (NASDAQ:PBIP). Northern Trust Corporation stated it has 0% of its portfolio in Prudential Bancorp, Inc. of PA (NASDAQ:PBIP). Wells Fargo Mn owns 0% invested in Prudential Bancorp, Inc. of PA (NASDAQ:PBIP) for 191 shares. Raffles Associates Limited Partnership holds 33,040 shares. Dimensional Fund LP holds 0% or 103,688 shares in its portfolio. Deutsche Natl Bank Ag accumulated 27,346 shares or 0% of the stock. Morgan Stanley stated it has 0% in Prudential Bancorp, Inc. of PA (NASDAQ:PBIP). Price Michael F has 121,287 shares. Blackrock Institutional Trust Na stated it has 4,124 shares.

Seidman Lawrence B decreased Si Finl Group Inc Md (NASDAQ:SIFI) stake by 23,375 shares to 565,470 valued at $8.87 million in 2016Q4. It also reduced Kearny Finl Corp Md stake by 351,206 shares and now owns 460,587 shares. Blue Hills Bancorp Inc (NASDAQ:BHBK) was reduced too.

Celgene Corporation is an integrated global biopharmaceutical company. The company has market cap of $99.24 billion. The Company, together with its subsidiaries, is engaged in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases through solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation. It has a 47.19 P/E ratio. The Company’s commercial-stage products include REVLIMID , POMALYST/IMNOVID (pomalidomide), OTEZLA (apremilast), ABRAXANE (paclitaxel albumin-bound particles for injectable suspension), VIDAZA, azacitidine for injection (generic version of VIDAZA) and THALOMID (thalidomide).

Investors sentiment decreased to 0.98 in Q4 2016. Its down 0.13, from 1.11 in 2016Q3. It is negative, as 57 investors sold Celgene Corporation shares while 470 reduced holdings. 116 funds opened positions while 398 raised stakes. 587.86 million shares or 1.69% more from 578.10 million shares in 2016Q3 were reported. The California-based West Oak Capital has invested 0% in Celgene Corporation (NASDAQ:CELG). Cullinan Assoc, a Kentucky-based fund reported 61,418 shares. Blackrock has 2.04 million shares. Koshinski Asset Mgmt reported 1,453 shares stake. Wealthtrust Axiom Lc reported 2,714 shares stake. Boston Prns owns 197,320 shares for 0.03% of their portfolio. Columbia Partners L L C Management holds 47,169 shares or 0.49% of its portfolio. Btc Cap Mngmt invested 0.86% of its portfolio in Celgene Corporation (NASDAQ:CELG). Girard Partners Limited holds 0.36% or 10,848 shares. Birch Hill Advsrs Lc has invested 3.5% in Celgene Corporation (NASDAQ:CELG). Moreover, Ashfield Prtnrs Lc has 1.42% invested in Celgene Corporation (NASDAQ:CELG). Clinton Group Inc owns 2,944 shares for 0.02% of their portfolio. Healthcor Mgmt Limited Partnership stated it has 1.50M shares. Hudson Bay Capital Management L P holds 0.02% of its portfolio in Celgene Corporation (NASDAQ:CELG) for 8,600 shares. Blackrock Invest Ltd Liability reported 1.79M shares stake.

Among 23 analysts covering Celgene Corporation (NASDAQ:CELG), 19 have Buy rating, 0 Sell and 4 Hold. Therefore 83% are positive. Celgene Corporation had 42 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was initiated by Stifel Nicolaus on Friday, July 15 with “Buy”. As per Thursday, August 4, the company rating was upgraded by BTIG Research. Standpoint Research downgraded Celgene Corporation (NASDAQ:CELG) on Wednesday, November 9 to “Hold” rating. The stock of Celgene Corporation (NASDAQ:CELG) earned “Buy” rating by Suntrust Robinson on Thursday, January 7. The rating was downgraded by Argus Research to “Hold” on Friday, May 5. The firm earned “Neutral” rating on Wednesday, June 1 by BTIG Research. The stock has “Buy” rating by Suntrust Robinson on Friday, April 29. As per Friday, July 24, the company rating was maintained by Cantor Fitzgerald. On Thursday, June 1 the stock rating was maintained by Mizuho with “Buy”. The firm earned “Strong-Buy” rating on Tuesday, September 1 by Raymond James.

Since February 27, 2017, it had 0 insider buys, and 4 sales for $3.72 million activity. 14,033 Celgene Corporation (NASDAQ:CELG) shares with value of $1.74M were sold by KAPLAN GILLA. VESSEY RUPERT had sold 4,785 shares worth $575,038. 7,500 Celgene Corporation (NASDAQ:CELG) shares with value of $911,625 were sold by CASEY MICHAEL D.